Novocure Chairman: Two-Pronged Opportunity | Mad Money | CNBC

It’s a little known biotech company with a new way to treat cancer. Novocure is developing innovative ways to attack tumors and it’s just getting started, Executive Chairman Bill Doyle told Jim Cramer.
» Subscribe to CNBC:
» Watch more Mad Money here:
» Read more about Novocure here:
"Mad Money" takes viewers inside the mind of one of Wall Street's most respected and successful money managers. Jim Cramer is your personal guide through the confusing jungle of Wall Street investing, navigating through both opportunities and pitfalls with one goal in mind -- to try to help you make money.

About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.

Get More Mad Money!
Read the latest news:
Watch full episodes:
Follow Mad Money on Twitter:
Like Mad Money on Facebook:
Follow Cramer on Twitter:

Connect with CNBC News Online!
Find CNBC News on Facebook:
Follow CNBC News on Twitter:
Follow CNBC News on Google+:
Follow CNBC News on Instagram:

Novocure Chairman: Two-Pronged Opportunity | Mad Money | CNBC

(Source: CNBC TV, February 27, 2018 at 11:31AM)

Comment Form is loading comments...